XRay-4-All IVS
Credit rating
Company information
About XRay-4-All IVS
XRay-4-All IVS (CVR number: 37774014) is a company from GREVE. The company reported a net sales of 0 mDKK in 2018, demonstrating a growth of 89.2 % compared to the previous year. The operating profit percentage was poor at -26.8 % (EBIT: -0 mDKK), while net earnings were -1.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -8.7 %, which can be considered poor and Return on Equity (ROE) was -13.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -39.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. XRay-4-All IVS's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | |
---|---|---|---|
Volume | |||
Net sales | -21.40 | 3.70 | 7.00 |
Gross profit | -21.40 | 3.70 | 1.69 |
EBIT | 13.19 | -3.76 | -1.88 |
Net earnings | 13.19 | -3.76 | -1.88 |
Shareholders equity total | -3.19 | -6.95 | -8.83 |
Balance sheet total (assets) | 21.44 | 13.75 | 13.57 |
Net debt | -0.27 | -13.75 | -13.57 |
Profitability | |||
EBIT-% | -101.6 % | -26.8 % | |
ROA | 53.6 % | -16.6 % | -8.7 % |
ROE | 61.5 % | -21.4 % | -13.7 % |
ROI | 62.3 % | -35.5 % | |
Economic value added (EVA) | 13.19 | -2.52 | -0.84 |
Solvency | |||
Equity ratio | -13.0 % | -33.6 % | -39.4 % |
Gearing | -663.0 % | ||
Relative net indebtedness % | -14.9 % | 187.9 % | 126.1 % |
Liquidity | |||
Quick ratio | 0.9 | 0.7 | 0.6 |
Current ratio | 0.9 | 0.7 | 0.6 |
Cash and cash equivalents | 21.44 | 13.75 | 13.57 |
Capital use efficiency | |||
Trade debtors turnover (days) | |||
Net working capital % | 14.9 % | -187.9 % | -126.1 % |
Credit risk | |||
Credit rating | C | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.